nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—CYP2C8—Pazopanib—kidney cancer	0.168	0.339	CbGbCtD
Mometasone—CYP2C8—Erlotinib—kidney cancer	0.12	0.242	CbGbCtD
Mometasone—CYP2C8—Paclitaxel—kidney cancer	0.11	0.222	CbGbCtD
Mometasone—CYP2C8—Sorafenib—kidney cancer	0.0975	0.197	CbGbCtD
Mometasone—Amcinonide—ANXA1—kidney cancer	0.00365	0.35	CrCbGaD
Mometasone—Hydrocortisone—ANXA1—kidney cancer	0.00154	0.148	CrCbGaD
Mometasone—Dexamethasone—ANXA1—kidney cancer	0.00115	0.11	CrCbGaD
Mometasone—Triamcinolone—BCHE—kidney cancer	0.000702	0.0673	CrCbGaD
Mometasone—Clobetasol propionate—CYP1A1—kidney cancer	0.000659	0.0631	CrCbGaD
Mometasone—Decreased appetite—Erlotinib—kidney cancer	0.000599	0.00123	CcSEcCtD
Mometasone—Nasopharyngitis—Capecitabine—kidney cancer	0.000598	0.00123	CcSEcCtD
Mometasone—Back pain—Vincristine—kidney cancer	0.000598	0.00123	CcSEcCtD
Mometasone—Fatigue—Erlotinib—kidney cancer	0.000594	0.00122	CcSEcCtD
Mometasone—Epistaxis—Paclitaxel—kidney cancer	0.000593	0.00122	CcSEcCtD
Mometasone—Infection—Sunitinib—kidney cancer	0.000593	0.00122	CcSEcCtD
Mometasone—Anorexia—Sorafenib—kidney cancer	0.000591	0.00121	CcSEcCtD
Mometasone—Sinusitis—Paclitaxel—kidney cancer	0.00059	0.00121	CcSEcCtD
Mometasone—Pain—Erlotinib—kidney cancer	0.000589	0.00121	CcSEcCtD
Mometasone—Myalgia—Dactinomycin—kidney cancer	0.000589	0.00121	CcSEcCtD
Mometasone—Dermatitis contact—Doxorubicin—kidney cancer	0.000587	0.0012	CcSEcCtD
Mometasone—Gastrointestinal pain—Vinblastine—kidney cancer	0.000586	0.0012	CcSEcCtD
Mometasone—Gastrointestinal pain—Everolimus—kidney cancer	0.000584	0.0012	CcSEcCtD
Mometasone—Asthma—Capecitabine—kidney cancer	0.000578	0.00119	CcSEcCtD
Mometasone—Influenza—Capecitabine—kidney cancer	0.000578	0.00119	CcSEcCtD
Mometasone—Influenza like illness—Doxorubicin—kidney cancer	0.000577	0.00118	CcSEcCtD
Mometasone—Vomiting—Pazopanib—kidney cancer	0.000575	0.00118	CcSEcCtD
Mometasone—Rash—Pazopanib—kidney cancer	0.00057	0.00117	CcSEcCtD
Mometasone—Nausea—Temsirolimus—kidney cancer	0.00057	0.00117	CcSEcCtD
Mometasone—Dermatitis—Pazopanib—kidney cancer	0.00057	0.00117	CcSEcCtD
Mometasone—Bronchospasm—Capecitabine—kidney cancer	0.000569	0.00117	CcSEcCtD
Mometasone—Anorexia—Sunitinib—kidney cancer	0.000569	0.00117	CcSEcCtD
Mometasone—Back pain—Gemcitabine—kidney cancer	0.000567	0.00116	CcSEcCtD
Mometasone—Candida infection—Doxorubicin—kidney cancer	0.000567	0.00116	CcSEcCtD
Mometasone—Abdominal pain—Vinblastine—kidney cancer	0.000567	0.00116	CcSEcCtD
Mometasone—Headache—Pazopanib—kidney cancer	0.000567	0.00116	CcSEcCtD
Mometasone—Rhinitis—Paclitaxel—kidney cancer	0.000566	0.00116	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000565	0.00116	CcSEcCtD
Mometasone—Abdominal pain—Everolimus—kidney cancer	0.000565	0.00116	CcSEcCtD
Mometasone—Body temperature increased—Everolimus—kidney cancer	0.000565	0.00116	CcSEcCtD
Mometasone—Gastrointestinal pain—Erlotinib—kidney cancer	0.000564	0.00116	CcSEcCtD
Mometasone—Infection—Dactinomycin—kidney cancer	0.000561	0.00115	CcSEcCtD
Mometasone—Pharyngitis—Paclitaxel—kidney cancer	0.00056	0.00115	CcSEcCtD
Mometasone—Bronchitis—Capecitabine—kidney cancer	0.000556	0.00114	CcSEcCtD
Mometasone—Dyspnoea—Sorafenib—kidney cancer	0.000553	0.00113	CcSEcCtD
Mometasone—Dyspepsia—Sorafenib—kidney cancer	0.000546	0.00112	CcSEcCtD
Mometasone—Abdominal pain—Erlotinib—kidney cancer	0.000545	0.00112	CcSEcCtD
Mometasone—Body temperature increased—Erlotinib—kidney cancer	0.000545	0.00112	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000544	0.00111	CcSEcCtD
Mometasone—Decreased appetite—Sorafenib—kidney cancer	0.000539	0.0011	CcSEcCtD
Mometasone—Anorexia—Dactinomycin—kidney cancer	0.000538	0.0011	CcSEcCtD
Mometasone—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000538	0.0011	CcSEcCtD
Mometasone—Nausea—Pazopanib—kidney cancer	0.000537	0.0011	CcSEcCtD
Mometasone—Paraesthesia—Sunitinib—kidney cancer	0.000536	0.0011	CcSEcCtD
Mometasone—Fatigue—Sorafenib—kidney cancer	0.000535	0.0011	CcSEcCtD
Mometasone—Dyspnoea—Sunitinib—kidney cancer	0.000532	0.00109	CcSEcCtD
Mometasone—Pain—Sorafenib—kidney cancer	0.00053	0.00109	CcSEcCtD
Mometasone—Myalgia—Vincristine—kidney cancer	0.000526	0.00108	CcSEcCtD
Mometasone—Dyspepsia—Sunitinib—kidney cancer	0.000525	0.00108	CcSEcCtD
Mometasone—Decreased appetite—Sunitinib—kidney cancer	0.000519	0.00106	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000515	0.00105	CcSEcCtD
Mometasone—Asthenia—Vinblastine—kidney cancer	0.000514	0.00105	CcSEcCtD
Mometasone—Fatigue—Sunitinib—kidney cancer	0.000514	0.00105	CcSEcCtD
Mometasone—Asthenia—Everolimus—kidney cancer	0.000512	0.00105	CcSEcCtD
Mometasone—Cough—Gemcitabine—kidney cancer	0.000512	0.00105	CcSEcCtD
Mometasone—Pain—Sunitinib—kidney cancer	0.00051	0.00105	CcSEcCtD
Mometasone—Immune system disorder—Paclitaxel—kidney cancer	0.00051	0.00104	CcSEcCtD
Mometasone—Mediastinal disorder—Paclitaxel—kidney cancer	0.000508	0.00104	CcSEcCtD
Mometasone—Gastrointestinal pain—Sorafenib—kidney cancer	0.000507	0.00104	CcSEcCtD
Mometasone—Pruritus—Everolimus—kidney cancer	0.000505	0.00104	CcSEcCtD
Mometasone—Anaphylactic shock—Vincristine—kidney cancer	0.000505	0.00103	CcSEcCtD
Mometasone—Infection—Vincristine—kidney cancer	0.000501	0.00103	CcSEcCtD
Mometasone—Urinary tract infection—Capecitabine—kidney cancer	0.000501	0.00103	CcSEcCtD
Mometasone—Conjunctivitis—Capecitabine—kidney cancer	0.000501	0.00103	CcSEcCtD
Mometasone—Chest pain—Gemcitabine—kidney cancer	0.000499	0.00102	CcSEcCtD
Mometasone—Myalgia—Gemcitabine—kidney cancer	0.000499	0.00102	CcSEcCtD
Mometasone—Arthralgia—Gemcitabine—kidney cancer	0.000499	0.00102	CcSEcCtD
Mometasone—Asthenia—Erlotinib—kidney cancer	0.000494	0.00101	CcSEcCtD
Mometasone—Decreased appetite—Dactinomycin—kidney cancer	0.000491	0.00101	CcSEcCtD
Mometasone—Diarrhoea—Vinblastine—kidney cancer	0.000491	0.00101	CcSEcCtD
Mometasone—Abdominal pain—Sorafenib—kidney cancer	0.00049	0.001	CcSEcCtD
Mometasone—Body temperature increased—Sorafenib—kidney cancer	0.00049	0.001	CcSEcCtD
Mometasone—Diarrhoea—Everolimus—kidney cancer	0.000489	0.001	CcSEcCtD
Mometasone—Gastrointestinal pain—Sunitinib—kidney cancer	0.000488	0.001	CcSEcCtD
Mometasone—Pruritus—Erlotinib—kidney cancer	0.000488	0.001	CcSEcCtD
Mometasone—Fatigue—Dactinomycin—kidney cancer	0.000487	0.000998	CcSEcCtD
Mometasone—Epistaxis—Capecitabine—kidney cancer	0.000486	0.000997	CcSEcCtD
Mometasone—Pain—Dactinomycin—kidney cancer	0.000483	0.00099	CcSEcCtD
Mometasone—Anorexia—Vincristine—kidney cancer	0.000481	0.000986	CcSEcCtD
Mometasone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000479	0.000981	CcSEcCtD
Mometasone—Infection—Gemcitabine—kidney cancer	0.000476	0.000975	CcSEcCtD
Mometasone—Back pain—Paclitaxel—kidney cancer	0.000475	0.000974	CcSEcCtD
Mometasone—Abdominal pain—Sunitinib—kidney cancer	0.000472	0.000967	CcSEcCtD
Mometasone—Body temperature increased—Sunitinib—kidney cancer	0.000472	0.000967	CcSEcCtD
Mometasone—Diarrhoea—Erlotinib—kidney cancer	0.000472	0.000967	CcSEcCtD
Mometasone—Rhinitis—Capecitabine—kidney cancer	0.000464	0.000952	CcSEcCtD
Mometasone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000462	0.000947	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00046	0.000943	CcSEcCtD
Mometasone—Pharyngitis—Capecitabine—kidney cancer	0.000459	0.000942	CcSEcCtD
Mometasone—Anorexia—Gemcitabine—kidney cancer	0.000456	0.000935	CcSEcCtD
Mometasone—Vomiting—Vinblastine—kidney cancer	0.000456	0.000935	CcSEcCtD
Mometasone—Vomiting—Everolimus—kidney cancer	0.000454	0.000931	CcSEcCtD
Mometasone—Paraesthesia—Vincristine—kidney cancer	0.000453	0.000929	CcSEcCtD
Mometasone—Rash—Everolimus—kidney cancer	0.00045	0.000923	CcSEcCtD
Mometasone—Dermatitis—Everolimus—kidney cancer	0.00045	0.000922	CcSEcCtD
Mometasone—Headache—Vinblastine—kidney cancer	0.000449	0.000921	CcSEcCtD
Mometasone—Angioedema—Paclitaxel—kidney cancer	0.000449	0.00092	CcSEcCtD
Mometasone—Headache—Everolimus—kidney cancer	0.000447	0.000917	CcSEcCtD
Mometasone—Abdominal pain—Dactinomycin—kidney cancer	0.000446	0.000915	CcSEcCtD
Mometasone—Body temperature increased—Dactinomycin—kidney cancer	0.000446	0.000915	CcSEcCtD
Mometasone—Asthenia—Sorafenib—kidney cancer	0.000445	0.000912	CcSEcCtD
Mometasone—Decreased appetite—Vincristine—kidney cancer	0.000439	0.000899	CcSEcCtD
Mometasone—Pruritus—Sorafenib—kidney cancer	0.000439	0.000899	CcSEcCtD
Mometasone—Vomiting—Erlotinib—kidney cancer	0.000438	0.000898	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000436	0.000894	CcSEcCtD
Mometasone—Fatigue—Vincristine—kidney cancer	0.000435	0.000892	CcSEcCtD
Mometasone—Rash—Erlotinib—kidney cancer	0.000435	0.000891	CcSEcCtD
Mometasone—Dermatitis—Erlotinib—kidney cancer	0.000434	0.00089	CcSEcCtD
Mometasone—Headache—Erlotinib—kidney cancer	0.000432	0.000885	CcSEcCtD
Mometasone—Pain—Vincristine—kidney cancer	0.000431	0.000885	CcSEcCtD
Mometasone—Paraesthesia—Gemcitabine—kidney cancer	0.00043	0.000881	CcSEcCtD
Mometasone—Cough—Paclitaxel—kidney cancer	0.000429	0.000879	CcSEcCtD
Mometasone—Asthenia—Sunitinib—kidney cancer	0.000428	0.000878	CcSEcCtD
Mometasone—Dyspnoea—Gemcitabine—kidney cancer	0.000427	0.000875	CcSEcCtD
Mometasone—Nausea—Vinblastine—kidney cancer	0.000426	0.000873	CcSEcCtD
Mometasone—Nausea—Everolimus—kidney cancer	0.000424	0.00087	CcSEcCtD
Mometasone—Diarrhoea—Sorafenib—kidney cancer	0.000424	0.00087	CcSEcCtD
Mometasone—Pruritus—Sunitinib—kidney cancer	0.000422	0.000865	CcSEcCtD
Mometasone—Immune system disorder—Capecitabine—kidney cancer	0.000418	0.000857	CcSEcCtD
Mometasone—Chest pain—Paclitaxel—kidney cancer	0.000418	0.000857	CcSEcCtD
Mometasone—Arthralgia—Paclitaxel—kidney cancer	0.000418	0.000857	CcSEcCtD
Mometasone—Myalgia—Paclitaxel—kidney cancer	0.000418	0.000857	CcSEcCtD
Mometasone—Mediastinal disorder—Capecitabine—kidney cancer	0.000417	0.000855	CcSEcCtD
Mometasone—Decreased appetite—Gemcitabine—kidney cancer	0.000416	0.000853	CcSEcCtD
Mometasone—Fatigue—Gemcitabine—kidney cancer	0.000413	0.000846	CcSEcCtD
Mometasone—Gastrointestinal pain—Vincristine—kidney cancer	0.000413	0.000846	CcSEcCtD
Mometasone—Pain—Gemcitabine—kidney cancer	0.000409	0.000839	CcSEcCtD
Mometasone—Nausea—Erlotinib—kidney cancer	0.000409	0.000839	CcSEcCtD
Mometasone—Fluticasone furoate—ABCB1—kidney cancer	0.000409	0.0392	CrCbGaD
Mometasone—Dry mouth—Paclitaxel—kidney cancer	0.000409	0.000838	CcSEcCtD
Mometasone—Diarrhoea—Sunitinib—kidney cancer	0.000408	0.000837	CcSEcCtD
Mometasone—Asthenia—Dactinomycin—kidney cancer	0.000405	0.000831	CcSEcCtD
Mometasone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000401	0.000822	CcSEcCtD
Mometasone—Abdominal pain—Vincristine—kidney cancer	0.000399	0.000818	CcSEcCtD
Mometasone—Body temperature increased—Vincristine—kidney cancer	0.000399	0.000818	CcSEcCtD
Mometasone—Infection—Paclitaxel—kidney cancer	0.000398	0.000816	CcSEcCtD
Mometasone—Vomiting—Sorafenib—kidney cancer	0.000394	0.000808	CcSEcCtD
Mometasone—Rash—Sorafenib—kidney cancer	0.000391	0.000801	CcSEcCtD
Mometasone—Dermatitis—Sorafenib—kidney cancer	0.000391	0.000801	CcSEcCtD
Mometasone—Back pain—Capecitabine—kidney cancer	0.00039	0.000799	CcSEcCtD
Mometasone—Headache—Sorafenib—kidney cancer	0.000388	0.000796	CcSEcCtD
Mometasone—Diarrhoea—Dactinomycin—kidney cancer	0.000386	0.000792	CcSEcCtD
Mometasone—Nasopharyngitis—Doxorubicin—kidney cancer	0.000386	0.000791	CcSEcCtD
Mometasone—Anorexia—Paclitaxel—kidney cancer	0.000382	0.000783	CcSEcCtD
Mometasone—Vomiting—Sunitinib—kidney cancer	0.000379	0.000778	CcSEcCtD
Mometasone—Body temperature increased—Gemcitabine—kidney cancer	0.000378	0.000776	CcSEcCtD
Mometasone—Rash—Sunitinib—kidney cancer	0.000376	0.000771	CcSEcCtD
Mometasone—Dermatitis—Sunitinib—kidney cancer	0.000376	0.00077	CcSEcCtD
Mometasone—Headache—Sunitinib—kidney cancer	0.000374	0.000766	CcSEcCtD
Mometasone—Asthma—Doxorubicin—kidney cancer	0.000373	0.000764	CcSEcCtD
Mometasone—Influenza—Doxorubicin—kidney cancer	0.000373	0.000764	CcSEcCtD
Mometasone—Nausea—Sorafenib—kidney cancer	0.000368	0.000755	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000365	0.000749	CcSEcCtD
Mometasone—Asthenia—Vincristine—kidney cancer	0.000362	0.000742	CcSEcCtD
Mometasone—Paraesthesia—Paclitaxel—kidney cancer	0.00036	0.000738	CcSEcCtD
Mometasone—Vomiting—Dactinomycin—kidney cancer	0.000359	0.000736	CcSEcCtD
Mometasone—Bronchitis—Doxorubicin—kidney cancer	0.000359	0.000735	CcSEcCtD
Mometasone—Dyspnoea—Paclitaxel—kidney cancer	0.000357	0.000733	CcSEcCtD
Mometasone—Rash—Dactinomycin—kidney cancer	0.000356	0.00073	CcSEcCtD
Mometasone—Nausea—Sunitinib—kidney cancer	0.000354	0.000727	CcSEcCtD
Mometasone—Dyspepsia—Paclitaxel—kidney cancer	0.000353	0.000723	CcSEcCtD
Mometasone—Cough—Capecitabine—kidney cancer	0.000352	0.000721	CcSEcCtD
Mometasone—Decreased appetite—Paclitaxel—kidney cancer	0.000348	0.000714	CcSEcCtD
Mometasone—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000346	0.00071	CcSEcCtD
Mometasone—Fatigue—Paclitaxel—kidney cancer	0.000346	0.000708	CcSEcCtD
Mometasone—Diarrhoea—Vincristine—kidney cancer	0.000345	0.000708	CcSEcCtD
Mometasone—Asthenia—Gemcitabine—kidney cancer	0.000343	0.000704	CcSEcCtD
Mometasone—Myalgia—Capecitabine—kidney cancer	0.000343	0.000703	CcSEcCtD
Mometasone—Chest pain—Capecitabine—kidney cancer	0.000343	0.000703	CcSEcCtD
Mometasone—Arthralgia—Capecitabine—kidney cancer	0.000343	0.000703	CcSEcCtD
Mometasone—Pain—Paclitaxel—kidney cancer	0.000343	0.000703	CcSEcCtD
Mometasone—Pruritus—Gemcitabine—kidney cancer	0.000339	0.000694	CcSEcCtD
Mometasone—Dry mouth—Capecitabine—kidney cancer	0.000336	0.000688	CcSEcCtD
Mometasone—Nausea—Dactinomycin—kidney cancer	0.000335	0.000688	CcSEcCtD
Mometasone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000328	0.000672	CcSEcCtD
Mometasone—Diarrhoea—Gemcitabine—kidney cancer	0.000328	0.000671	CcSEcCtD
Mometasone—Infection—Capecitabine—kidney cancer	0.000327	0.00067	CcSEcCtD
Mometasone—Methylprednisolone—ABCB1—kidney cancer	0.000326	0.0313	CrCbGaD
Mometasone—Triamcinolone—PTGS2—kidney cancer	0.000323	0.031	CrCbGaD
Mometasone—Urinary tract infection—Doxorubicin—kidney cancer	0.000323	0.000662	CcSEcCtD
Mometasone—Conjunctivitis—Doxorubicin—kidney cancer	0.000323	0.000662	CcSEcCtD
Mometasone—Vomiting—Vincristine—kidney cancer	0.000321	0.000658	CcSEcCtD
Mometasone—Rash—Vincristine—kidney cancer	0.000318	0.000652	CcSEcCtD
Mometasone—Dermatitis—Vincristine—kidney cancer	0.000318	0.000652	CcSEcCtD
Mometasone—Body temperature increased—Paclitaxel—kidney cancer	0.000317	0.00065	CcSEcCtD
Mometasone—Abdominal pain—Paclitaxel—kidney cancer	0.000317	0.00065	CcSEcCtD
Mometasone—Headache—Vincristine—kidney cancer	0.000316	0.000648	CcSEcCtD
Mometasone—Epistaxis—Doxorubicin—kidney cancer	0.000314	0.000643	CcSEcCtD
Mometasone—Anorexia—Capecitabine—kidney cancer	0.000313	0.000643	CcSEcCtD
Mometasone—Sinusitis—Doxorubicin—kidney cancer	0.000312	0.000639	CcSEcCtD
Mometasone—Vomiting—Gemcitabine—kidney cancer	0.000304	0.000624	CcSEcCtD
Mometasone—Rash—Gemcitabine—kidney cancer	0.000302	0.000619	CcSEcCtD
Mometasone—Dermatitis—Gemcitabine—kidney cancer	0.000302	0.000618	CcSEcCtD
Mometasone—Headache—Gemcitabine—kidney cancer	0.0003	0.000615	CcSEcCtD
Mometasone—Nausea—Vincristine—kidney cancer	0.0003	0.000614	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.0003	0.000614	CcSEcCtD
Mometasone—Rhinitis—Doxorubicin—kidney cancer	0.000299	0.000613	CcSEcCtD
Mometasone—Pharyngitis—Doxorubicin—kidney cancer	0.000296	0.000607	CcSEcCtD
Mometasone—Paraesthesia—Capecitabine—kidney cancer	0.000295	0.000605	CcSEcCtD
Mometasone—Dyspnoea—Capecitabine—kidney cancer	0.000293	0.000601	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.000291	0.0446	CbGpPWpGaD
Mometasone—Dyspepsia—Capecitabine—kidney cancer	0.00029	0.000594	CcSEcCtD
Mometasone—Asthenia—Paclitaxel—kidney cancer	0.000288	0.00059	CcSEcCtD
Mometasone—Decreased appetite—Capecitabine—kidney cancer	0.000286	0.000586	CcSEcCtD
Mometasone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—kidney cancer	0.000284	0.0435	CbGpPWpGaD
Mometasone—Nausea—Gemcitabine—kidney cancer	0.000284	0.000583	CcSEcCtD
Mometasone—Fatigue—Capecitabine—kidney cancer	0.000284	0.000581	CcSEcCtD
Mometasone—Pruritus—Paclitaxel—kidney cancer	0.000284	0.000581	CcSEcCtD
Mometasone—Pain—Capecitabine—kidney cancer	0.000281	0.000577	CcSEcCtD
Mometasone—Diarrhoea—Paclitaxel—kidney cancer	0.000274	0.000562	CcSEcCtD
Mometasone—Immune system disorder—Doxorubicin—kidney cancer	0.00027	0.000553	CcSEcCtD
Mometasone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000269	0.000551	CcSEcCtD
Mometasone—Mediastinal disorder—Doxorubicin—kidney cancer	0.000269	0.000551	CcSEcCtD
Mometasone—Betamethasone—PTGS2—kidney cancer	0.000265	0.0254	CrCbGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.00026	0.0398	CbGpPWpGaD
Mometasone—Abdominal pain—Capecitabine—kidney cancer	0.00026	0.000533	CcSEcCtD
Mometasone—Body temperature increased—Capecitabine—kidney cancer	0.00026	0.000533	CcSEcCtD
Mometasone—Vomiting—Paclitaxel—kidney cancer	0.000255	0.000522	CcSEcCtD
Mometasone—Rash—Paclitaxel—kidney cancer	0.000253	0.000518	CcSEcCtD
Mometasone—Dermatitis—Paclitaxel—kidney cancer	0.000252	0.000518	CcSEcCtD
Mometasone—Back pain—Doxorubicin—kidney cancer	0.000251	0.000515	CcSEcCtD
Mometasone—Headache—Paclitaxel—kidney cancer	0.000251	0.000515	CcSEcCtD
Mometasone—Prednisone—ABCB1—kidney cancer	0.000249	0.0239	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—FOSL2—kidney cancer	0.000248	0.038	CbGpPWpGaD
Mometasone—Dexamethasone—CYP1A1—kidney cancer	0.000247	0.0236	CrCbGaD
Mometasone—Nausea—Paclitaxel—kidney cancer	0.000238	0.000488	CcSEcCtD
Mometasone—Asthenia—Capecitabine—kidney cancer	0.000236	0.000484	CcSEcCtD
Mometasone—Pruritus—Capecitabine—kidney cancer	0.000233	0.000477	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—kidney cancer	0.000231	0.0354	CbGpPWpGaD
Mometasone—Prednisolone—ABCB1—kidney cancer	0.00023	0.022	CrCbGaD
Mometasone—Cough—Doxorubicin—kidney cancer	0.000227	0.000465	CcSEcCtD
Mometasone—Betamethasone—ABCB1—kidney cancer	0.000225	0.0216	CrCbGaD
Mometasone—Diarrhoea—Capecitabine—kidney cancer	0.000225	0.000461	CcSEcCtD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	0.000223	0.0341	CbGpPWpGaD
Mometasone—Myalgia—Doxorubicin—kidney cancer	0.000221	0.000453	CcSEcCtD
Mometasone—Arthralgia—Doxorubicin—kidney cancer	0.000221	0.000453	CcSEcCtD
Mometasone—Chest pain—Doxorubicin—kidney cancer	0.000221	0.000453	CcSEcCtD
Mometasone—Dry mouth—Doxorubicin—kidney cancer	0.000216	0.000443	CcSEcCtD
Mometasone—Anaphylactic shock—Doxorubicin—kidney cancer	0.000212	0.000435	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.000211	0.0323	CbGpPWpGaD
Mometasone—Infection—Doxorubicin—kidney cancer	0.000211	0.000432	CcSEcCtD
Mometasone—Vomiting—Capecitabine—kidney cancer	0.000209	0.000429	CcSEcCtD
Mometasone—Rash—Capecitabine—kidney cancer	0.000207	0.000425	CcSEcCtD
Mometasone—Dermatitis—Capecitabine—kidney cancer	0.000207	0.000425	CcSEcCtD
Mometasone—Headache—Capecitabine—kidney cancer	0.000206	0.000422	CcSEcCtD
Mometasone—NR3C1—Endoderm Differentiation—CER1—kidney cancer	0.000203	0.0311	CbGpPWpGaD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	0.000203	0.031	CbGpPWpGaD
Mometasone—Anorexia—Doxorubicin—kidney cancer	0.000202	0.000414	CcSEcCtD
Mometasone—Nausea—Capecitabine—kidney cancer	0.000195	0.000401	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000193	0.000396	CcSEcCtD
Mometasone—Paraesthesia—Doxorubicin—kidney cancer	0.00019	0.00039	CcSEcCtD
Mometasone—Dyspnoea—Doxorubicin—kidney cancer	0.000189	0.000388	CcSEcCtD
Mometasone—Dyspepsia—Doxorubicin—kidney cancer	0.000187	0.000383	CcSEcCtD
Mometasone—Decreased appetite—Doxorubicin—kidney cancer	0.000184	0.000378	CcSEcCtD
Mometasone—Fatigue—Doxorubicin—kidney cancer	0.000183	0.000375	CcSEcCtD
Mometasone—Pain—Doxorubicin—kidney cancer	0.000181	0.000372	CcSEcCtD
Mometasone—Hydrocortisone—ABCB1—kidney cancer	0.000176	0.0169	CrCbGaD
Mometasone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000173	0.000355	CcSEcCtD
Mometasone—Abdominal pain—Doxorubicin—kidney cancer	0.000168	0.000344	CcSEcCtD
Mometasone—Body temperature increased—Doxorubicin—kidney cancer	0.000168	0.000344	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—FOSL1—kidney cancer	0.000166	0.0253	CbGpPWpGaD
Mometasone—Dexamethasone—PTGS2—kidney cancer	0.000154	0.0148	CrCbGaD
Mometasone—Asthenia—Doxorubicin—kidney cancer	0.000152	0.000312	CcSEcCtD
Mometasone—Pruritus—Doxorubicin—kidney cancer	0.00015	0.000308	CcSEcCtD
Mometasone—NR3C1—Endoderm Differentiation—BMP7—kidney cancer	0.00015	0.0229	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—HNF1B—kidney cancer	0.00015	0.0229	CbGpPWpGaD
Mometasone—Diarrhoea—Doxorubicin—kidney cancer	0.000145	0.000297	CcSEcCtD
Mometasone—Vomiting—Doxorubicin—kidney cancer	0.000135	0.000276	CcSEcCtD
Mometasone—Rash—Doxorubicin—kidney cancer	0.000134	0.000274	CcSEcCtD
Mometasone—Dermatitis—Doxorubicin—kidney cancer	0.000134	0.000274	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—kidney cancer	0.000133	0.0204	CbGpPWpGaD
Mometasone—Headache—Doxorubicin—kidney cancer	0.000133	0.000272	CcSEcCtD
Mometasone—Dexamethasone—ABCB1—kidney cancer	0.000131	0.0126	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—JUND—kidney cancer	0.000128	0.0196	CbGpPWpGaD
Mometasone—Nausea—Doxorubicin—kidney cancer	0.000126	0.000258	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—EPAS1—kidney cancer	0.000109	0.0167	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—HNF1A—kidney cancer	0.000109	0.0167	CbGpPWpGaD
Mometasone—CYP2C8—Xenobiotics—CYP1A1—kidney cancer	0.000107	0.0164	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000103	0.0157	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.000102	0.0156	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000101	0.0155	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—ACY1—kidney cancer	9.84e-05	0.0151	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL13—kidney cancer	9.46e-05	0.0145	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	8.7e-05	0.0133	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	8.14e-05	0.0125	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	8.01e-05	0.0123	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS1—kidney cancer	7.98e-05	0.0122	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	7.62e-05	0.0117	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	7.17e-05	0.011	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—HIF1A—kidney cancer	6.87e-05	0.0105	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	6.73e-05	0.0103	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	6.3e-05	0.00965	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	5.66e-05	0.00867	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	5.66e-05	0.00866	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	5.59e-05	0.00855	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—ALDH1A1—kidney cancer	5.39e-05	0.00825	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP1A1—kidney cancer	5.14e-05	0.00787	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—APC—kidney cancer	5.1e-05	0.00781	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	4.44e-05	0.0068	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	4.38e-05	0.00671	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	4.29e-05	0.00656	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	4.27e-05	0.00653	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	4.18e-05	0.0064	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	4.05e-05	0.0062	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.6e-05	0.00551	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	3.59e-05	0.00549	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	3.51e-05	0.00537	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HARS—kidney cancer	3.51e-05	0.00537	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	3.47e-05	0.00531	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—HIF1A—kidney cancer	3.45e-05	0.00528	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	3.43e-05	0.00526	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	3.42e-05	0.00524	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	3.41e-05	0.00523	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	3.39e-05	0.00519	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.31e-05	0.00507	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	3.3e-05	0.00505	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTT1—kidney cancer	3.17e-05	0.00485	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	3.09e-05	0.00473	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS2—kidney cancer	3.06e-05	0.00468	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	3.04e-05	0.00465	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	3.01e-05	0.0046	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EIF5B—kidney cancer	2.98e-05	0.00457	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	2.98e-05	0.00456	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—PTGS1—kidney cancer	2.97e-05	0.00454	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	2.74e-05	0.0042	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.68e-05	0.00411	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.62e-05	0.00401	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	2.49e-05	0.00381	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	2.44e-05	0.00374	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	2.37e-05	0.00362	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	2.25e-05	0.00345	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTP1—kidney cancer	2.2e-05	0.00336	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	2.17e-05	0.00331	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CTNNB1—kidney cancer	2.06e-05	0.00316	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTM1—kidney cancer	2.02e-05	0.00309	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	1.99e-05	0.00305	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	1.99e-05	0.00304	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	1.94e-05	0.00296	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EEF2—kidney cancer	1.92e-05	0.00294	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	1.91e-05	0.00293	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	1.89e-05	0.00289	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TET2—kidney cancer	1.84e-05	0.00282	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	1.8e-05	0.00275	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	1.78e-05	0.00273	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TCEB1—kidney cancer	1.69e-05	0.00258	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TCEB2—kidney cancer	1.69e-05	0.00258	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ACY1—kidney cancer	1.68e-05	0.00258	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	1.58e-05	0.00241	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	1.57e-05	0.0024	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.43e-05	0.0022	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PDHB—kidney cancer	1.43e-05	0.00219	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—POMC—kidney cancer	1.43e-05	0.00218	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—RPL14—kidney cancer	1.37e-05	0.0021	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CCBL1—kidney cancer	1.34e-05	0.00206	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.22e-05	0.00186	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GLIPR1—kidney cancer	1.17e-05	0.00179	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPAT—kidney cancer	1.17e-05	0.00179	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.15e-05	0.00176	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.14e-05	0.00174	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HSPB1—kidney cancer	1.12e-05	0.00171	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	1.12e-05	0.00171	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—FH—kidney cancer	1.08e-05	0.00166	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APRT—kidney cancer	1.08e-05	0.00166	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.06e-05	0.00162	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PSMD7—kidney cancer	1.04e-05	0.00159	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GPC3—kidney cancer	1.02e-05	0.00156	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CA2—kidney cancer	9.92e-06	0.00152	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALAD—kidney cancer	9.66e-06	0.00148	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ST3GAL2—kidney cancer	9.43e-06	0.00144	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—JUNB—kidney cancer	9.32e-06	0.00143	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALDH1A1—kidney cancer	9.22e-06	0.00141	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC5A3—kidney cancer	8.84e-06	0.00135	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PGK1—kidney cancer	8.84e-06	0.00135	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LDHB—kidney cancer	8.67e-06	0.00133	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CDKN2B—kidney cancer	7.59e-06	0.00116	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CA9—kidney cancer	7.51e-06	0.00115	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.34e-06	0.00112	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CRABP1—kidney cancer	6.39e-06	0.000978	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	6.11e-06	0.000935	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ITPR2—kidney cancer	5.94e-06	0.000909	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.48e-06	0.000838	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ACHE—kidney cancer	5.42e-06	0.000829	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTT1—kidney cancer	5.42e-06	0.000829	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SCARB1—kidney cancer	5.13e-06	0.000785	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS1—kidney cancer	5.08e-06	0.000777	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PSMD7—kidney cancer	4.98e-06	0.000762	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—BCHE—kidney cancer	4.72e-06	0.000722	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC5A5—kidney cancer	4.66e-06	0.000714	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC2A1—kidney cancer	4.5e-06	0.000689	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.37e-06	0.000669	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.81e-06	0.000583	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTP1—kidney cancer	3.75e-06	0.000575	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCB1—kidney cancer	3.55e-06	0.000544	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM1—kidney cancer	3.45e-06	0.000528	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.27e-06	0.000501	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MAPK3—kidney cancer	3.02e-06	0.000463	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MYC—kidney cancer	2.94e-06	0.00045	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.69e-06	0.000411	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—POMC—kidney cancer	2.44e-06	0.000373	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS2—kidney cancer	1.95e-06	0.000298	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTEN—kidney cancer	1.7e-06	0.00026	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.2e-06	0.000183	CbGpPWpGaD
